title: [A case of advanced esophageal cancer with no recurrence treated biweekly with postoperative docetaxel/nedaplatin combined chemotherapy after non-curative surgery].
abstract: We report a case of non-curatively resected esophageal cancer with no recurrence biweekly treated with postoperative docetaxel/nedaplatin combined chemotherapy. A 59-year-old woman underwent non-curative resection with esophagectomy for advanced esophageal cancer with direct invasion to the descending aorta in August, 2007. Postoperatively, she was treated biweekly with docetaxel/nedaplatin combined chemotherapy 32 times. In this period, there was no finding in the enhanced CTs, and clinically she was free from recurrence. The quality of life of this patient was also good. Thus, postoperative biweekly docetaxel/nedaplatin combined chemotherapy could be effective for advanced esophageal cancer after non-curative surgery and might be promising for long-term survival. This combined chemotherapy could be carried out on an outpatient basis, and the quality of life could also be preserved. More experience must be accumulated using this chemotherapy.
authors.affiliation: Department of Surgery, Chibaken Saiseikai Narashino Hospital.
authors.forename: Katsumi
authors.initials: K
authors.lastname: Sugimoto
authors.forename: Kensyuu
authors.initials: K
authors.lastname: Sasaki
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Karaki
authors.forename: Tomohisa
authors.initials: T
authors.lastname: Okaya
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Suzuki
authors.forename: Shinniti
authors.initials: S
authors.lastname: Hayashi
authors.forename: Kazuo
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Hideo
authors.initials: H
authors.lastname: Yamamori
authors.forename: Isamu
authors.initials: I
authors.lastname: Sugano
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D000077143:Docetaxel; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction; D043823:Taxoids / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D009944:Organoplatinum Compounds; D043823:Taxoids; D000077143:Docetaxel; C053989:nedaplatin